Alexandra Trkola

University of Zurich — Switzerland

Immunology and Microbiology · Life Sciences

69h-index19.5kcitations347works5.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

HIV Research and Treatment(192), HIV/AIDS drug development and treatment(106), HIV/AIDS Research and Interventions(81), Immune Cell Function and Interaction(68), HIV-related health complications and treatments(47)

Publications335 total

Viral metagenomic sequencing reveals rare pathogens and improves diagnostic accuracy in neuroinflammatory disorders
Diagnostic Microbiology and Infectious Disease·2025· 1 citedOpen Access
Untargeted Metabolite Profile Associations With Body Mass Index, Waist–Hip Ratio, and Antiretroviral Therapy in >1300 People With HIV: The Swiss HIV Cohort Study
The Journal of Infectious Diseases·2025Open Access
Infection with Mycobacterium tuberculosis alters the antibody response to HIV-1
PLoS Pathogens·2025· 1 citedOpen Access
Population pharmacokinetics of bictegravir in real-world people with HIV
Journal of Antimicrobial Chemotherapy·2025· 1 citedOpen Access
Low Trauma Fractures in People With HIV: Longitudinal Time Trends in the Swiss HIV Cohort Study, 2009–2022
Clinical Infectious Diseases·2025Open Access
Types of Myocardial Infarction in People With HIV in Switzerland
Open Forum Infectious Diseases·2025· 1 citedOpen Access
In danger: HIV vaccine research and development in Europe
PLOS Global Public Health·2025· 1 citedOpen Access
Type I interferon autoantibody footprints reveal neutralizing mechanisms and allow inhibitory decoy design
The Journal of Experimental Medicine·2025· 10 citedOpen Access
Rare twin cysteine residues in the HIV-1 envelope variable region 1 link to neutralization escape and breadth development
Cell Host & Microbe·2025· 2 citedOpen Access
Low agreement and frequent invalid controls in two SARS-CoV-2 T-cell assays in people with compromised immune function
PLoS ONE·2025Open Access
Assessing bnAb potency in the context of HIV-1 envelope conformational plasticity
PLoS Pathogens·2025· 3 citedOpen Access
HIV-1 Low-Level Viremia Predicts Viral Failure in Participants on Antiretroviral Therapy in the Swiss HIV Cohort Study
Clinical Infectious Diseases·2024· 8 citedOpen Access
Assessing bnAb potency in the context of HIV-1 Envelope conformational plasticity
2024Open Access
The XbnAb Cohort: 304 people with broadly neutralizing antibody activity to HIV-1
2024Open Access
Rare twin cysteine residues in the HIV-1 envelope variable region 1 link to neutralization escape and breadth development
2024Open Access
ART-DEX: A novel strategy to monitor broadly neutralizing antibody activity during antiretroviral therapy of HIV-1
STAR Protocols·2024Open Access
Decoupling HIV-1 antiretroviral drug inhibition from plasma antibody activity to evaluate broadly neutralizing antibody therapeutics and vaccines
Cell Reports Medicine·2024· 1 citedOpen Access
External Validation of Serologic Scores for the Detection of Liver Steatosis Among People With HIV
Open Forum Infectious Diseases·2024Open Access
Loss of tolerance precedes triggering and lifelong persistence of pathogenic type I interferon autoantibodies
The Journal of Experimental Medicine·2024· 28 citedOpen Access
Antibody and T-Cell Response to Bivalent Booster SARS-CoV-2 Vaccines in People With Compromised Immune Function: COVERALL-3 Study
The Journal of Infectious Diseases·2024· 2 citedOpen Access
page 1 of 17Next →

Frequent Co-authors

John P. Moore(19), Huldrych F. Günthard(18), Enos Bernasconi(13), Manuel Battegay(11), Matthias Cavassini(11), Peter Rusert(9), Sabine Yerly(9), Andri Rauch(9), Hansjakob Furrer(9), Michael Huber(8), Thomas Klimkait(8), Heiner C. Bucher(8), Luigia Elzi(8), Pietro Vernazza(8), Martin Purtscher(7), Rainer Weber(7), Alexandra Calmy(7), Laurent Kaiser(7), Philip Tarr(7), Tom Ketas(6)